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A common clinical definition of a chronic tympanic
membrane perforation (TMP) is a perforation, which is
still open after 3 months. Why the healing of a chronic
TMP is arrested is still an enigma. Attempts to generate
an animal model for studying the healing pattern of a
chronic TMP have until recently been disappointing. How-
ever, several studies by the Umeå group, Ny T, Hellström S,
Li J, Shen Y and collaborators [1-4] have shown that
chronic TMPs can be evoked in a mouse model (plg−/−)
lacking plasminogen.
In the Commentary by Wang et al. [5] the plg−/−
model is questioned and data interpreted such as it in
fact may represent an acute TMP model. They claim
that the healing studies do not illustrate chronicity of
the TMP and that morphologic evidence, such as
otoscopic and histological images, is lacking. The authors
are supporting their suggestions by adding a solid refer-
ence list including our plasminogen reports.
Unfortunately Wang et al. have not carefully scruti-
nized our studies on the plg−/− model. In the initial
report on the mice model [1] the TMPs were followed
for 143 days, thus more than 3 months. Furthermore the
TMPs were analysed both otomicroscopically and histo-
logically. Otomicroscopically, it appears that all TMPs* Correspondence: sten.hellstrom@karolinska.se
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in any medium, provided the original work is pwere closed at days 72 and 143. However, histology
showed that all TMPs were still open (Table one in our
initial report [1]), but covered by a thick amorphous tissue
on the inner surface of the TM (Figure one: G and H and
text p. 514 in our initial report [1]). The morphological
analysis of the structure also showed the mucocutaneous
junction to be located on the inner medial side of the
perforation border, characterizing a chronic TMP.
In our more recent publications [2-4] the plg−/− TMP
model has been utilized for numerous studies of the
healing pattern. To shorten the time for receiving
results, and with the knowledge that plg−/− TMPs never
heal, most experiments have been initiated 9 days after
creating the chronic TMP. The rational for this is that
the biological pattern; neutrophil infiltration, fibrin and
necrotic tissue deposition, and retarded keratinocyte
migration, is histologically the same at day 9 and day
143 after perforation [1]. In another study [3] we showed
that the early inflammatory response in the plg−/− model
is not altered compared to that in wildtype mice. The
chronicity of the perforation in the longterm healing
experiment can therefore not be explained by an impair-
ment of the early inflammatory response but rather by an
impairment in activation of the inflammatory cells [3].
In conclusion, in contrast to the authors of the
Commentary, we have shown, in our publications,
that this plg−/− model is a ”true” chronic TMP model.
Furthermore our reports show that chronic TMP
perforations will heal when treated with plg eitheris an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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These findings will be the rational for the clinical
studies on chronic TMPs in humans, which are in
progress.
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